Comparative study of lansoprazole and esomeprazole in first-line triple therapy for Helicobacter pylori infection-an open label randomized controlled trial

被引：0
|
作者：
Noda, Teruyo [1 ]
Tamaki, Hiroyuki [1 ]
Arasawa, Shuichi [1 ]
Izuta, Masako [1 ]
Kubo, Atsushi [1 ]
Ogawa, Chikara [1 ]
Matsunaka, Toshihiro [1 ]
Shibatouge, Mitsushige [1 ]
机构：
[1] Takamatsu Red Cross Hosp, Takamatsu, Kagawa, Japan
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2015年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1418
引用
收藏
页码：123 / 123
页数：1
相关论文
共 50 条
  • [1] OPEN-LABEL RANDOMIZED CONTROLLED TRIAL OF VONOPRAZAN AND ESOMEPRAZOLE IN FIRST-LINE TRIPLE THERAPY AGAINST HELICOBACTER PYLORI INFECTION
    Tamaki, Hiroyuki
    Morita, Masahiro
    Noda, Teruyo
    Izuta, Masako
    Kubo, Atsushi
    Ogawa, Chikara
    Matsunaka, Toshihiro
    Shibatoge, Mitsushige
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S248 - S248
  • [2] An open-label, multicenter, randomized controlled trial of vonoprazan versus esomeprazole as part of first-line triple therapy for Helicobacter pylori infection
    Tamaki, Hiroyuki
    Morita, Masahiro
    Omura, Akina
    Kubo, Atsushi
    Ogawa, Chikara
    Matsunaka, Toshihiro
    Shibatoge, Mitsushige
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 36 - 36
  • [3] AN OPEN-LABEL, MULTI-CENTER, RANDOMIZED, SUPERIORITY TRIAL OF VONOPRAZAN VERSUS ESOMEPRAZOLE AS PART OF FIRST-LINE TRIPLE THERAPY FOR HELICOBACTER PYLORI INFECTION
    Tamaki, Hiroyuki
    Noda, Teruyo
    Morita, Masahiro
    Omura, Akina
    Kubo, Atsushi
    Ogawa, Chikara
    Matsunaka, Toshihiro
    Shibatoge, Mitsushige
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S89 - S89
  • [4] Comparative study of esomeprazole and lansoprazole in triple therapy for eradication of Helicobacter pylori in Japan
    Nishida, Tsutomu
    Tsujii, Masahiko
    Tanimura, Hirohisa
    Tsutsui, Shusaku
    Tsuji, Shingo
    Takeda, Akira
    Inoue, Atsuo
    Fukui, Hiroyuki
    Yoshio, Toshiyuki
    Kishida, Osamu
    Ogawa, Hiroyuki
    Oshita, Masahide
    Kobayashi, Ichizo
    Zushi, Shinichiro
    Ichiba, Makoto
    Uenoyama, Naoto
    Yasunaga, Yuichi
    Ishihara, Ryu
    Yura, Mamoru
    Komori, Masato
    Egawa, Satoshi
    Iijima, Hideki
    Takehara, Tetsuo
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (15) : 4362 - 4369
  • [5] Comparative study of esomeprazole and lansoprazole in triple therapy for eradication of Helicobacter pylori in Japan
    Tsutomu Nishida
    Masahiko Tsujii
    Hirohisa Tanimura
    Shusaku Tsutsui
    Shingo Tsuji
    Akira Takeda
    Atsuo Inoue
    Hiroyuki Fukui
    Toshiyuki Yoshio
    Osamu Kishida
    Hiroyuki Ogawa
    Masahide Oshita
    Ichizo Kobayashi
    Shinichiro Zushi
    Makoto Ichiba
    Naoto Uenoyama
    Yuichi Yasunaga
    Ryu Ishihara
    Mamoru Yura
    Masato Komori
    Satoshi Egawa
    Hideki Iijima
    Tetsuo Takehara
    [J]. World Journal of Gastroenterology, 2014, 20 (15) : 4362 - 4369
  • [6] Moxifloxacin-Tetracycline-Lansoprazole Triple Therapy for First-Line Treatment of Helicobacter pylori Infection: A Prospective Study
    Tas, Adnan
    Akbal, Erdem
    Kocak, Erdem
    Koklu, Seyfettin
    [J]. HELICOBACTER, 2011, 16 (01) : 52 - 54
  • [7] Berberine-, Allicin- or Clarithromycin-Based Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection: an Open-Label, Randomized Trial
    Zhang, Xiaomei
    Yang, Yunsheng
    Gang, Sun
    Yang, Chao
    Lu, Mingliang
    Zhi, Junli
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S398 - S398
  • [8] Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
    Liou, Jyh-Ming
    Chen, Chieh-Chang
    Chen, Mei-Jyh
    Chen, Chien-Chuan
    Chang, Chi-Yang
    Fang, Yu-Jen
    Lee, Ji-Yuh
    Hsu, Shih-Jer
    Luo, Jiing-Chyuan
    Chang, Wen-Hsiung
    Hsu, Yao-Chun
    Tseng, Cheng-Hao
    Tseng, Ping-Huei
    Wang, Hsiu-Po
    Yang, Ueng-Cheng
    Shun, Chia-Tung
    Lin, Jaw-Town
    Lee, Yi-Chia
    Wu, Ming-Shiang
    [J]. LANCET, 2013, 381 (9862): : 205 - 213
  • [9] Randomized trial for comparison of esomeprazole and rabeprazole in the first-line eradication therapy for Helicobacter pylori infection regarding serum level of pepsinogens
    Shimoyama, Tadashi
    Chinda, Daisuke
    Sawada, Yoshihiko
    Komai, Kazuo
    Sasaki, Yoshio
    Chiba, Hironobu
    Saito, Yoshiharu
    Matsuzaka, Masashi
    Fukuda, Shinsaku
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 66 - 66
  • [10] Randomized Trial Comparing Esomeprazole and Rabeprazole in First-line Eradication Therapy for Helicobacter pylori Infection based on the Serum Levels of Pepsinogens
    Shimoyama, Tadashi
    Chinda, Daisuke
    Sawada, Yoshihiko
    Komai, Kazuo
    Chiba, Hironobu
    Saito, Yoshiharu
    Sasaki, Yoshio
    Matsuzaka, Masashi
    Fukuda, Shinsaku
    [J]. INTERNAL MEDICINE, 2017, 56 (13) : 1621 - 1627
12345